


EU’s €12.5M Bet on Oncomatryx and Antibody-Drug Conjugates (ADCs)
European biotech received a confidence boost as the EU’s European

From Early Detection to Tumor “Education”: Syantra’s Bold Bet on cfRNA in Cancer Tech
A New Direction in Liquid Biopsy When Syantra Inc. announced

Breaking the Bias: How Precision Medicine Can Overcome Ancestral Disparities
In the rapidly advancing field of precision medicine, where treatments

Marea Biotech Secures $190 Million for Heart Disease Research
Introduction Marea Biotech, a pioneering company in the biotech industry,
